nintedanib

The drug is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, and interstitial lung disease associated with systemic sclerosis.

Form: capsules, soft gelatin

ATC: L01EX09

Manufacturer: Boehringer Ingelheim Pharma GmbH & Co.KG (primary (blister) and secondary packaging, labeling, quality control, microbiological purity quality control and batch release of the medicinal product)

The drug is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases with a progressive phenotype, and interstitial lung disease associated with systemic sclerosis.

Form: capsules, soft gelatin

ATC: L01EX09

Manufacturer: Boehringer Ingelheim Pharma GmbH & Co.KG (primary (blister) and secondary packaging, labeling, quality control, microbiological purity quality control and batch release of the medicinal product)